Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs.

Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs. Abstract Text:

Arginine vasotocin (AVT), in doses of 1.5 microgram, administered intranasally to two narcoleptics (a male aged 42 years and a female aged 35 years), as well as to 5 symptomatic hypersomniacs (3 females and 2 males), aged 25-57 years, induced very rapidly in most instances in sleep with REM periods at onset and markedly increased in amount of REM sleep during a fixed period of 180 min of sleep recording. After AVT administration there was a significant shortening of the time of occurrence of the first REM sleep period both in narcoleptics (t test = 0.05 greater than P greater than 0.025) and in symptomatic hypersomniacs (t test = 0.02 greater than P greater than 0.01).

Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Electroencephalography and clinical neurophysiolog

VOLUME: 53

Page Numbers: 325-8

Journal Abbreviation: Electroencephalogr Clin Neurop

ISSN: 0013-4694

DAY: 9

MONTH: Mar

YEAR: 1982

Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375035

Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs. Keywords Mesh Terms:

KEYWORDS: Vasotocin

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs. Information

Substance Name: Vasotocin

Registry Number: 9034-50-8

Grant and Affiliation Information for Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs.

AFFILIATION:

Country: NETHERLANDS

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Electroencephalogr Clin Neurop

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs Related Publications

• 100-W quasi-continuous-wave diode radially pumped microchip composite Yb:YAG laser.
• Boosting Linear Logistic Regression for Single Trial ERP Detection in Rapid Serial Visual Presentation Tasks.
• Catalytic nitric oxide synthase activity in the white and gray matter regions of the spinal cord of rabbits.
• Channel selection and feature projection for cognitive load estimation using ambulatory EEG.
• Continuous activity monitoring and intelligent contextual prompting to improve medication adherence.
• Effects of arginine vasotocin on REM sleep in narcoleptics and in symptomatic hypersomniacs.
• Embedded Assessment Algorithms within Home-Based Cognitive Computer Game Exercises for Elders.
• Extension of pulmonary adenocarcinoma into the left atrium.
• Increased Melanogenesis is a Risk Factor for Oxidative DNA Damage- Study on Cultured Melanocytes and Atypical Nevus Cells.
• Integrating american indian/alaska native culture into shared storybook intervention.
• Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment.
• The SAPHO syndrome in a 16-year-old boy: coincidence of acne conglobata and osteoarthritis.
• [Importance of genetics in raising the resistance of animals]
• [Methods of determining the mutagenic activity of chemical compounds]
• [Not Available.]
• [Not Available.]
• [On the importance of genetics in veterinary science]
• [Outbreak of Q fever in a municipal abattoir]
• [The role of genetic factors in the etiology of disseminated lupus erythematosus (DLE)]